Nurix Therapeutics Inc (NRIX)

Nurix Therapeutics Inc (NRIX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.9B; returns 1 day -0.7%, 1 week +3.8%, 1 year +143.7%.

Nurix Therapeutics Inc. (NRIX) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of oral, small molecule medicines based on targeted protein degradation (TPD). The company leverages its proprietary DEL-AI platform and expertise in E3 ligases to develop novel therapies.

Groups NRIX belongs to

• Biotechnology
• Clinical Stage Biotech
• Clinical Stage
• Biopharmaceutical
• Oncology
• Hematology
• Autoimmune Diseases
• Strategic Partnerships
• Drug Discovery

NRIX financial model: income statement, cash flow and balance sheet